Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-26), IPOPEMA Securities's 3-1 Month Momentum % is 14.15%.
The industry rank for IPOPEMA Securities's 3-1 Month Momentum % or its related term are showing as below:
WAR:IPE's 3-1 Month Momentum % is ranked better than 84.18% of 822
companies
in the Capital Markets industry
Industry Median: -3.135
vs WAR:IPE: 14.15
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
IPOPEMA Securities 3-1 Month Momentum % Related Terms
WAR:IPE vs MS, GS, SCHW: 3-1 Month Momentum % Comparison
For the Capital Markets subindustry, IPOPEMA Securities's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IPOPEMA Securities 3-1 Month Momentum % vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, IPOPEMA Securities's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where IPOPEMA Securities's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IPOPEMA Securities (WAR:IPE) has a 3-1 Month Momentum % of 14.15% as of Jul. 26, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on IPOPEMA Securities and its competitors. According to the industry distribution chart, IPOPEMA Securities ranks #130 out of 822 companies in the Capital Markets industry, placing it in the top 15.8%.
Is IPOPEMA Securities' 3-1 Month Momentum % too high?
IPOPEMA Securities' current 3-1 Month Momentum % is 14.15%. Based on the distribution chart, IPOPEMA Securities ranks #130 out of 822 companies in the Capital Markets industry, which is in the top quartile — a strong position relative to peers. Overall, IPOPEMA Securities has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IPOPEMA Securities' 3-1 Month Momentum % compare to MS and GS?
According to the Capital Markets industry distribution chart, IPOPEMA Securities ranks #130 out of 822 companies for 3-1 Month Momentum %. This places IPOPEMA Securities in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Capital Markets company?
A good 3-1 Month Momentum % depends on the Capital Markets industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on IPOPEMA Securities and its competitors. IPOPEMA Securities's current 3-1 Month Momentum % is 14.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IPOPEMA Securities stock overvalued right now?
Based on GuruFocus' analysis, IPOPEMA Securities (WAR:IPE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł3.62, compared to a current price of zł7.54 — trading 108.3% above its estimated fair value. The current 3-1 Month Momentum % is 14.15%. IPOPEMA Securities' overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For IPOPEMA Securities (WAR:IPE), the current 3-1 Month Momentum % is 14.15% as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IPOPEMA Securities (WAR:IPE) Overvalued in 2026?
Based on GuruFocus' analysis, IPOPEMA Securities stock appears to be overvalued.
The current stock price of zł7.54 is trading 108.3% above its estimated GF Value™ of zł3.62.
GuruFocus considers IPOPEMA Securities to be Significantly Overvalued.
Key valuation signals for WAR:IPE:
3-1 Month Momentum %: 14.15%
GF Value™: zł3.62 vs. price of zł7.54 (108.3% above fair value)
No single metric tells the full story. See the WAR:IPE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.
57GF Score
Get the complete analysis for WAR:IPE
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:IPE has been successfully added to your 
